Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017696

CEO and Chairman sold 44,445 shares at an average $11.80 ($524,352)

  • CEO and Chairman acquired 29,630 shares (option exercise)
  • CEO and Chairman acquired 14,815 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBINS CHAD M CEO and Chairman 2022-03-07 Option exercise +14,815 $6.32 $93,631 1,930,969 D
ROBINS CHAD M CEO and Chairman 2022-03-07 Sale −500 $12.22 $6,110 1,930,469 D
ROBINS CHAD M CEO and Chairman 2022-03-07 Sale −14,315 $11.53 $165,052 1,916,154 D
ROBINS CHAD M CEO and Chairman 2022-03-08 Option exercise −14,815 $6.32 $93,631 1,930,969 D
ROBINS CHAD M CEO and Chairman 2022-03-08 Sale −14,815 $11.38 $168,595 1,916,154 D
ROBINS CHAD M CEO and Chairman 2022-03-09 Option exercise −14,815 $6.32 $93,631 1,930,969 D
ROBINS CHAD M CEO and Chairman 2022-03-09 Sale −14,815 $12.46 $184,595 1,916,154 D
Derivatives
ROBINS CHAD M CEO and Chairman 2022-03-07 Option exercise · Stock Option (Right to Buy) −14,815 785,185 D
ROBINS CHAD M CEO and Chairman 2022-03-08 Option exercise · Stock Option (Right to Buy) −14,815 770,370 D
ROBINS CHAD M CEO and Chairman 2022-03-09 Option exercise · Stock Option (Right to Buy) −14,815 755,555 D
Open-market sales · 44,445 sh · avg $11.80 · $524,352
Loading xslF345X03/doc4.xml…